The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
<i>Background and objectives</i>: Spinal muscular atrophy (SMA) is a neurodegenerative disease that leads to progressive proximal muscle weakness and muscle atrophy. To assess the beneficial and adverse effects of nusinersen, a promising intervention for SMA, we conducted a systematic se...
Auteurs principaux: | , , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
MDPI AG
2022-02-01
|
Collection: | Medicina |
Sujets: | |
Accès en ligne: | https://www.mdpi.com/1648-9144/58/2/213 |